We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -4.26% | 5.625 | 5.25 | 6.00 | 6.00 | 5.50 | 5.875 | 744,959 | 16:18:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -1.26 | 6.47M |
TIDMGDR
RNS Number : 6825B
Genedrive PLC
05 April 2017
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them - Replacement
The following amendments have been made to the 'Director/PDMR Shareholding' announcement released today at 11:17am under RNS No 6708B.
50,000 options were granted to each of Allan Brown and Gino Miele and not 117,647.
All other details remain unchanged.
The full amended text is shown below,
genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that it has granted share options ("Options") to certain of its directors and senior management to acquire a total of 632,884 ordinary shares of 1.5p each in the capital of the Company under the Company's Share Option Scheme.
The Options have been granted with an exercise price equal to the close price on the day before grant and vest after a period of three years. The Options are exercisable over the period of 10 years from the date of grant.
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
1. Details of the person discharging managerial responsibilities / person closely associated --- ----------------------------------------------------------------------------- a. Name 1. David Budd 2. Allan Brown 3. Gino Miele --- ------------------------------ --------------------------------------------- 2. Reason for the notification --- ----------------------------------------------------------------------------- a. Position/status 1. Chief Executive Officer 2. Chief Operating Officer 3. R&D Director --- ------------------------------ --------------------------------------------- a. Initial notification Initial notification /Amendment --- ------------------------------ --------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------------------------- a. Name genedrive plc --- ------------------------------ --------------------------------------------- b. LEI N/A --- ------------------------------ --------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------------------- a. Description Options over ordinary shares of of the 1.5 pence each Financial instrument, type of instrument Identification code --- ------------------------------ --------------------------------------------- b. Nature of Grant of options pursuant to and the transaction in accordance with the terms of the Company's Share Option Scheme dated 28 November 2007. --- ------------------------------ --------------------------------------------- c. Price(s) Price(s) Option Volume(s) and volume(s) price(s) ------------------ ---------- ---------- David Budd 42.5p 397,590 ------------------ ---------- ---------- Allan Brown 42.5p 50,000 ------------------ ---------- ---------- Gino Miele 42.5p 50,000 ------------------ ---------- ---------- --- ------------------------------ --------------------------------------------- d. Aggregated information N/A * Aggregated volume * Price --- ------------------------------ --------------------------------------------- e. Date of the 2016-04-04; UTC time transaction --- ------------------------------ --------------------------------------------- f. Place of Outside trading venue - shares the transaction to be admitted to AIM market of London Stock Exchange plc on exercise of options --- ------------------------------ ---------------------------------------------
For further details please contact:
genedrive plc +44 (0)161 989 0245 David Budd: CEO Matthew Fowler: CFO Peel Hunt LLP +44 (0)207 418 8900 James Steel Oliver Jackson Consilium Strategic Communications +44 (0)203 709 5700 Chris Gardner Matthew Neal Laura Thornton genedrive@consilium-comms.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHSSLFFIFWSEDL
(END) Dow Jones Newswires
April 05, 2017 07:39 ET (11:39 GMT)
1 Year Genedrive Chart |
1 Month Genedrive Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions